Physician profile
Mark J Page
NPI 1578561270
$2,693.31
in general payments reported to CMS, 2019-2025
10 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $713 · 2020: $103 · 2021: $66.82 · 2022: $325 · 2023: $275 · 2024: $1,033 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $485.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,888.44 | 2019-2025 | Precision 1, Dailies Total1, Air Optix Color |
| Johnson & Johnson Vision Care, INC. | $312.76 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $158.16 | 2019-2020 | |
| Synergeyes, INC. | $99.66 | 2019 | |
| Coopervision INC. | $68.71 | 2020-2023 | Myday Contact Lens |
| Carl Zeiss Meditec, INC. | $60.36 | 2019 | |
| Optos, INC. | $48.56 | 2019 | |
| Bausch & Lomb Americas INC. | $20.08 | 2024 | Alden Scleral Zenlens |
| Abb Con-Cise Optical Group LLC | $18.29 | 2019 | |
| Visioneering Technologies, INC. | $18.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.